Skip to main content
×
Home
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 20
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Vasilevsky, Sam Stojanov, Milos Greub, Gilbert and Baud, David 2016. Chlamydial polymorphic membrane proteins: regulation, function and potential vaccine candidates. Virulence, Vol. 7, Issue. 1, p. 11.


    Derrick, Tamsyn Roberts, Chrissy h. Last, Anna R. Burr, Sarah E. and Holland, Martin J. 2015. Trachoma and Ocular Chlamydial Infection in the Era of Genomics. Mediators of Inflammation, Vol. 2015, p. 1.


    Fan, Huizhou and Zhong, Guangming 2015. Molecular Medical Microbiology.


    Patel, Manishkumar Lin, Shu-An Boddicker, Melissa A. DeMaula, Christopher Connolly, Brett Bednar, Bohumil Heinrichs, Jon H. and Smith, Jeffrey G. 2015. QuantitativeIn VivoDetection ofChlamydia muridarumAssociated Inflammation in a Mouse Model Using Optical Imaging. Mediators of Inflammation, Vol. 2015, p. 1.


    Stary, G. Olive, A. Radovic-Moreno, A. F. Gondek, D. Alvarez, D. Basto, P. A. Perro, M. Vrbanac, V. D. Tager, A. M. Shi, J. Yethon, J. A. Farokhzad, O. C. Langer, R. Starnbach, M. N. and von Andrian, U. H. 2015. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells. Science, Vol. 348, Issue. 6241, p. aaa8205.


    Mabey, David C.W. Hu, Victor Bailey, Robin L. Burton, Matthew J. and Holland, Martin J. 2014. Towards a safe and effective chlamydial vaccine: Lessons from the eye. Vaccine, Vol. 32, Issue. 14, p. 1572.


    Igietseme, Joseph U Eko, Francis O and Black, Carolyn M 2011. Chlamydiavaccines: recent developments and the role of adjuvants in future formulations. Expert Review of Vaccines, Vol. 10, Issue. 11, p. 1585.


    Rockey, Daniel D Wang, Jie Lei, Lei and Zhong, Guangming 2009. Chlamydia vaccine candidates and tools for chlamydial antigen discovery. Expert Review of Vaccines, Vol. 8, Issue. 10, p. 1365.


    MABEY, D. C. W. HOLLAND, M. J. VISWALINGAM, N. D. GOH, B. T. ESTREICH, S. MACFARLANE, A. DOCKRELL, H. M. and TREHARNE, J. D. 2008. Lymphocyte proliferative responses to chlamydial antigens in human chlamydial eye infections. Clinical & Experimental Immunology, Vol. 86, Issue. 1, p. 37.


    Pal, Sukumar Peterson, Ellena M. and de la Maza, Luis M. 2005. Vaccination of newborn mice induces a strong protective immune response against respiratory and genital challenges with Chlamydia trachomatis. Vaccine, Vol. 23, Issue. 46-47, p. 5351.


    Huang, Jin DeGraves, Fred J. Lenz, Stephen D. Gao, Dongya Feng, Pu Li, Dan Schlapp, Tobias and Kaltenboeck, Bernhard 2002. The quantity of nitric oxide released by macrophages regulatesChlamydia-induced disease. Proceedings of the National Academy of Sciences, Vol. 99, Issue. 6, p. 3914.


    BRUNHAM, ROBERT C. and McCLARTY, GRANT 2000. Sexually Transmitted Diseases.


    Ghaem-Maghami, Sadaf and Lewis, David J.M. 1999. Chlamydia trachomatis: the role of cellular and humoral immune mechanisms in the development of blindness. Current Opinion in Infectious Diseases, Vol. 12, Issue. 3, p. 229.


    Mäkelä, P Helena 1999. Special Section Future Trendsin Vaccination: Is cardiovascular disease preventable by vaccination?. Annals of Medicine, Vol. 31, Issue. 1, p. 61.


    ZHANG, YANG, SHEN, and BRUNHAM, 1999. Characterization of immune responses following intramuscular DNA immunization with the MOMP gene of Chlamydia trachomatis mouse pneumonitis strain. Immunology, Vol. 96, Issue. 2, p. 314.


    Stagg, Andrew J. 1998. Vaccines against Chlamydia: approaches and progress. Molecular Medicine Today, Vol. 4, Issue. 4, p. 166.


    WARD, MICHAEL E. 1995. The immunobiology and immunopathology of chlamydial infections. APMIS, Vol. 103, Issue. 7-8, p. 769.


    Ballard, R.C. Block, C. Koornhof, H.J. and Haitas, B. 1979. DELAYED HYPERSENSITIVITY TO CHLAMYDIA TRACHOMATIS: CAUSE OF CHRONIC PROSTATITIS?. The Lancet, Vol. 314, Issue. 8155, p. 1305.


    Collier, L. H. Sowa, J. and Sowa, Shiona 1972. The serum and conjunctival antibody response to trachoma in Gambian children. Journal of Hygiene, Vol. 70, Issue. 04, p. 727.


    Sowa, J. Collier, L. H. and Sowa, Shiona 1971. A comparison of the iodine and fluorescent antibody methods for staining trachoma inclusions in the conjunctiva. Journal of Hygiene, Vol. 69, Issue. 04, p. 693.


    ×

Trachoma vaccine field trials in The Gambia

  • Shiona Sowa (a1), J. Sowa (a1), L. H. Collier (a1) and W. A. Blyth (a1)
  • DOI: http://dx.doi.org/10.1017/S0022172400042157
  • Published online: 01 May 2009
Abstract
SUMMARY

The ability of two live trachoma vaccines to protect against naturally acquired infection was tested in young Gambian children. With a mineral oil adjuvant vaccine prepared from a Gambian strain of trachoma (MRC–187) a barely significant measure of protection was demonstrable 6 months after the first dose, but not at 1 year, despite a reinforcing dose given 6 months after the first. In a later trial an aqueous vaccine prepared from the ‘fast-killing’ variants of strains ‘SA–2’ and ‘ASGH’ failed to induce immunity. Two years after vaccination, the proportion of vaccinated children progressing to cicatricial trachoma was less than in the controls, and the average severity of the disease in terms of clinical score was greater; vaccine-induced hypersensitivity may have contributed to this result.

Irrespective of whether they had received trachoma vaccine, children with completely normal eyes at the outset were less likely to acquire trachoma than those with slight conjunctival folliculosis or papillary hyperplasia. In children acquiring trachoma, there was a highly significant positive correlation between severity of the disease and the presence of conjunctival inclusions. The pattern of trachoma differed significantly in the two villages used in both trials; the prev alence, severity and proportion of inclusion-positive subjects were all higher in the village with the greater population density.

An efficient follow-up organization, use of a slit-lamp for clinical observations, and a scoring system for recording physical signs are all desirable for trachoma vaccine field trials.

We are highly indebted to Dr G. Turner (Lister Institute, Elstree, Herts) for his assistance in making the vaccine used for Trial II; to Dr N. M. Lam (Pfizer Ltd.) and Dr C. H. Smith (Evans Medical Ltd.) for making the Trial III vaccine; to Dr I. A. Sutherland (M.R.C. Statistical Unit) for his advice and help with the statistical aspects; to the Pennsylvania Refinery Co. Inc. for a generous gift of Drakeol 6 VR; and to Mr M. Race for his invaluable technical assistance in The Gambia. We are also grateful to the Director and staff of the M.R.C. Laboratories, The Gambia, for various facilities; and to The Gambian Government for per mission to undertake these trials.

Copyright
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

S. D. Bell & B. Theobald (1962). Differentiation of trachoma strains on the basis of inmnmization against toxic death of mice. Ann. N.Y. Acad. Sci. 98, 337.

L. H. Collier & A. Smith (1967). Dissemination and immunogenicity of live TRIO agents in baboons after parenteral injection. Am. J. Ophthal. 63, 1589.

R. Dulbecco & M. VOGT (1954). Plaque formation and isolation of pure lines with polio myolitis viruses. J. exp. Med. 99, 167.

D. M. Graham (1967). Growth and immunogenicity of TRIC agents in mice. Am. J. Ophthal. 63, 1173.

L. Hanna , E. Jawetz , P. Thygeson & C. Dawson (1960). Trachoma viruses isolated in United States. I. Growth in embryonated eggs. Proc. Soc. exp. Biol. Med. 104, 142.

C. H. Mordhorst (1967). Experimental infections and immunogenicity of TRIO agents in monkeys. Am. J. Ophthal. 63, 1603.

R. L. Nichols , A. A. Bobb , N. A. Haddad & D. E. Mccomb (1967). Immunofluorescent studies of the microbiologic epidemiology of trachoma in Saudi Arabia. Am. J. Ophthal. 63, 1372.

P. Reeve & J. Taverne (1962). A simple method for total particle counts of trachoma and inclusion blennorrhoea viruses. Nature, Lond. 195, 923.

P. Reeve & J. Taverns (1967). An assessment of the evidence for regarding the Tang strain as an authentic TRIO agent. Am. J. Ophthal. 63, 1437.

S. P. Wang , J. T. Grayston & E. R. Alexander (1967). Trachoma vaccine studies in monkeys. Am. J. Ophthal. 63, 1615.

R. L. Woolridge , J. T. Grayston , I. H. Chang , K. H. Cheng , C. Y. Yang & C. Neave (1967). Field trial of a monovalent and of a bivalent mineral oil adjuvant trachoma vaccine in Taiwan school children. Am. J. Ophthal. 63, 1645.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×